CHIEF FINANCIAL OFFICER
Fri, Nov 8, 2024
Nov 8
exercised or converted securities in ACLX
7,200 shares @ $8.66
Increased holdings by +104.10%
Net across this filing: -66.80% (-5,154 shares)
Option Exercise
Sale tied to a same-time option exercise
ACLXArcellx, Inc.
Health CareBiotechnology